左心室辅助装置支持患者中除颤器发生器更换:血肿与感染风险
该回顾性单中心分析纳入2014年1月至2018年12月间接受ICD发生器更换的277例患者,其中251例有完整6个月随访,190例无LVAD,61例使用LVAD。LVAD患者主要复合终点(临床显著囊袋血肿和/或CIED感染)发生率是非LVAD患者的3.5倍(每100患者年39.14 vs 11.07,p=0.048)。
要点
- LVAD患者ICD发生器更换后临床显著囊袋血肿和/或CIED感染发生率是非LVAD患者的3.5倍。
- 需翻修的临床显著囊袋血肿在LVAD组发生率近4倍于非LVAD组(p=0.042)。
- 囊袋装置感染率在LVAD患者中约为非LVAD患者的16倍(p=0.002)。
核心结论
- 与无LVAD患者相比,LVAD患者在ICD发生器更换后临床显著囊袋血肿和CIED感染发生率更高。
- 该信息应在ICD发生器更换适应证的决策过程中加以考虑。
研究设计与样本
- 回顾性单中心分析,纳入2014年1月至2018年12月间所有LVAD和非LVAD患者中进行的ICD发生器更换。
- 277例患者接受ICD发生器更换,其中251例有完整的6个月随访(190例无LVAD,61例使用LVAD)。
- 主要终点为ICD发生器更换后6个月内临床显著囊袋血肿和/或CIED感染的复合终点。
主要发现
- 主要复合终点事件率在LVAD患者中为每100患者年39.14,在非LVAD患者中为每100患者年11.07(p=0.048),LVAD组是非LVAD组的3.5倍。
- 需翻修的临床显著囊袋血肿在LVAD组发生率近4倍于非LVAD组(p=0.042)。
- 囊袋装置感染率在LVAD患者中约为非LVAD患者的16倍(p=0.002)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The majority (89%) of left ventricular assist device (LVAD) patients have an implantable cardioverter-defibrillator (ICD) in place. Due to the advances of modern-day LVAD therapy, more patients are on support for longer. This inevitably leads to more LVAD patients facing ICD generator battery depletion. Until now, there are insufficient data regarding periprocedural risks of generator replacements in a high-risk group like the LVAD cohort. METHODS: A retrospective, single-center analysis of pocket-related outcomes of all ICD generator replacements in LVAD and Non-LVAD patients between January 2014 and December 2018. The primary outcome was the combined endpoint of clinically significant pocket hematoma and/or cardiac implantable electronic device (CIED) infection in the first 6 months after ICD generator exchange. The clinically significant hematoma was defined as hematoma requiring reoperation, prolongation of hospitalization, or interruption of anticoagulation. The cumulative incidence function was calculated for the primary endpoint. RESULTS: Two hundred seventy-seven patients underwent ICD generator exchange in our clinic in this time. Of these, 251 patients had a complete 6-month follow-up regarding clinically significant pocket hematomas and pocket infections. One hundred ninety patients had no LVAD, and 61 patients were on LVAD support. The rate of the primary combined endpoint clinically significant pocket hematoma and/or CIED infection was 3.5 times higher in LVAD patients compared to the non-LVAD cohort (event rate 39.14 vs 11.07 per 100 patient-years, p = 0.048). Clinically significant pocket hematomas necessitating revision occurred nearly 4 times more often in the LVAD group (p = 0.042). Pocket device infection rates were around 16 times higher in LVAD patients compared to non-LVAD patients (p = 0.002). CONCLUSIONS: Compared to Non-LVAD patients, LVAD patients exhibit a relevant higher rate of clinically significant pocket hematoma and CIED infection after ICD generator exchange. This information should additionally be considered in the decision-making process regarding the indication for ICD generator exchange.
引用
- Eulert-Grehn JJ, Sterner I, Schoenrath F, et al. Defibrillator generator replacements in patients with left ventricular assist device support: The risks of hematoma and infection. J Heart Lung Transplant. 2022. PMID: 35422347. doi:10.1016/j.healun.2022.02.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。